A study testing whether a GLP-1 medicine can help people with obesity lose weight.

Recruiting now. Registry record last updated January 22, 2026.

Who can join: Adults 18+, have obesity, BMI 30+.
What you take: Check ClinicalTrials.gov for this trial's study groups and what each group receives.
How long it lasts: The full study runs about 6 years.
What you get: Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.

This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.

Check my fit →

Phase Phase 4Sponsor University of Missouri-ColumbiaDrug GLP-1 receptor agonistClass OtherSites 1 USEnrollment target 150

What this study is for

Primary condition: Morbid Obesity. Also studied in: Metabolic Syndrome, Diabetes Mellitus, Hypertension, Obstructive Sleep Apnea of Adult.

Full scientific study title: Impact GLP-1 Agonists Following Bariatric.

Who can join

Age18 and upSexAnyBMI30 or higher

Adults 18+, have obesity, BMI 30+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Full medical eligibility (for you and your doctor)verbatim from the registry

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

Greater than 18 years of age
Participation in care by one of the surgeons at MU Health Care
Undergoing surgical weight loss through the Weight Management and Metabolic Center
Body mass index of 30-80 kg/m2
Meet insurance criteria, as set forth by the patient's insurance policy, to qualify for coverage for weight loss surgery or as a self-pay patient for the weight loss procedure

Key exclusion criteria

Pregnant patient
Desire to not participate
Age less than 18
Patient fails to fulfill insurance mandated criteria and is not interested in paying cash for their procedure
Not taking a GLP-1 agonist as part of standard medical care

Where this trial is enrolling

This trial has 1 sites across 1 state. Contact a site coordinator directly to start screening.

Missouri1 site

University of Missouri Hospital
Columbia, Missouri
Andrew Wheeler, MD573-882-5609wheeleraa@health.missouri.edu

Follow this trial

We email you if NCT06132477 changes status, adds new sites in your state, or if a similar trial opens for the same condition.

Timeline

Started enrolling: February 1, 2024. Expected completion: July 2030. Last updated on ClinicalTrials.gov: January 22, 2026.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site LinkedIn Contact

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.